Noura Fathy Elmongy
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Noura Fathy Elmongy has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Rania M. Salama
Pharmacology and Toxicology Department, Faculty of Pharmacy, Misr International University (MIU), Cairo, Egypt
2 shared publications Ahmed Shaaban Mohamed
Department of Gynecology and Obstetric; Faculty of medicine; Alazhar University; Egypt
1 shared publication- Azza H. Abd Elwahab
Physiology Department, Faculty of Medicine for Girls, Al-Azhar University, Cairo, Egypt
1 shared publication - Ghada A. Abdel-Latif
Pharmacology and Toxicology Department, Faculty of Pharmacy, Misr International University, Cairo 11511, Egypt
1 shared publication Ibrahim M Shatla
Department of Physiology, Damietta Faculty of Medicine, Al-Azhar University, Damietta, Egypt
1 shared publicationIsmail Hussein
1 shared publication
Latest Publications
- 1 October 2022
- Published by Egyptian Knowledge Bank in Bulletin of Egyptian Society for Physiological Sciences
- Vol. 42 (4) , 344-358
Cardioprotective effect of Cinnamomum zeylanicum extract on rats fed on high fat high fructose diet
Background: As a result of the increased consumption of sugar-rich and fatty-products, and the increase in the preference for such products, metabolic disorders are becoming more common at a younger age. Hyperlipidemia, insulin resistance [IR] and inflammatory status induced by high fat high fructose diet [HFHFD] increase the risk of developing cardiovascular diseases [CVDs] which are the leading cause of death worldwide. Objective: This study is aiming to determine the effects of HFHFD on cardiovascular disease [CVD]-related parameters. Also, the possible protective and curative effects of cinnamon extract on cardiac diseases. Methodology: Fifty adult male Sprague Dawley rats were divided into five groups: Group I: [control]. Group II rats were fed a diet with 45 kcal% fat and drink fructose 60% [HFHFD] for 8w. Group III: fed on HFHFD and pioglitazone [PGZ 20 mg/kg/b.wt]. Group IV: fed on HFHFD and cinnamon extract200mg/kg.b.w. Group V: fed on HFHFD and treated with combination of PGZ drug and cinnamon extract. Results: HFHFD administration resulted signs of cardiomyopathy revealed by significant increase in blood glucose, serum insulin, homeostasis model assessment of IR [HOMA- IR] index with disturbed lipid profile. Also, significant increase in serum cardiac enzymes, inflammatory cytokines and oxidative stress markers were also noticed. PGZ and cinnamon extract treatment resulted in a significant decrease in glucose, insulin, and HOMA- IR index, amelioration of lipid profile, cardiac enzymes, inflammatory cytokines and oxidative stress markers
- 1 October 2022
- Published by Egyptian Knowledge Bank in Bulletin of Egyptian Society for Physiological Sciences
- Vol. 42 (4) , 344-358
Cardioprotective effect of Cinnamomum zeylanicum extract on rats fed on high fat high fructose diet
Background: As a result of the increased consumption of sugar-rich and fatty-products, and the increase in the preference for such products, metabolic disorders are becoming more common at a younger age. Hyperlipidemia, insulin resistance [IR] and inflammatory status induced by high fat high fructose diet [HFHFD] increase the risk of developing cardiovascular diseases [CVDs] which are the leading cause of death worldwide. Objective: This study is aiming to determine the effects of HFHFD on cardiovascular disease [CVD]-related parameters. Also, the possible protective and curative effects of cinnamon extract on cardiac diseases. Methodology: Fifty adult male Sprague Dawley rats were divided into five groups: Group I: [control]. Group II rats were fed a diet with 45 kcal% fat and drink fructose 60% [HFHFD] for 8w. Group III: fed on HFHFD and pioglitazone [PGZ 20 mg/kg/b.wt]. Group IV: fed on HFHFD and cinnamon extract200mg/kg.b.w. Group V: fed on HFHFD and treated with combination of PGZ drug and cinnamon extract. Results: HFHFD administration resulted signs of cardiomyopathy revealed by significant increase in blood glucose, serum insulin, homeostasis model assessment of IR [HOMA- IR] index with disturbed lipid profile. Also, significant increase in serum cardiac enzymes, inflammatory cytokines and oxidative stress markers were also noticed. PGZ and cinnamon extract treatment resulted in a significant decrease in glucose, insulin, and HOMA- IR index, amelioration of lipid profile, cardiac enzymes, inflammatory cytokines and oxidative stress markers
- 14 April 2022
- Published by Egyptian Knowledge Bank in International Journal of Medical Arts
MYOMECTOMY DURING CAESAREAN SECTION: Is it effective and safe procedure?
Objective: patients hospitalized for an elective or selected cesarean section to examine the efficacy and safety of myomectomy during the surgery. Material and methods: As part of this investigation, 71 individuals with single or multiple myomas who were hospitalized to the prenatal care unit and those who came to the emergency ward for selective caesarean section were selected for inclusion in this prospective observational study. Main outcome measures: Blood transfusion, postoperative ecobolic usage, time required for surgery, problems during surgery, re-laparotomy to control bleeding or to perform hysterectomies, postoperative complications, and length of stay following surgery are all factors to consider. Results: There is no longer any danger in doing a myomectomy during a caesarean section, as previously stated. The average blood loss during surgery is 518.3 + 80.9 mm3, not including bleeding from the CS incision. There was no significant bleeding following surgery. The preoperative mean HB level/dl was 10.35 + 0.7, while the postoperative mean level/dl was 10.08 + 0.9. There were no postoperative complications for 84.4 percent of the women who had surgery. 82.2 percent of myomas occur in the uterine body, and the most prevalent kind is intramural [75.6 percent ]. Sixty-six percent of women had a myoma that was no larger than 5 centimeters. A caesarean myomectomy was accomplished in 80% of instances in less than an hour. After the birth of the infant, in 93.3 percent of instances, a myomectomy was performed. There was never a single occurrence of morbid fever. Myomectomy was performed successfully in all 71 of the patients who were admitted to the hospital following the procedure.
- 14 April 2022
- Published by Egyptian Knowledge Bank in International Journal of Medical Arts
MYOMECTOMY DURING CAESAREAN SECTION: Is it effective and safe procedure?
Objective: patients hospitalized for an elective or selected cesarean section to examine the efficacy and safety of myomectomy during the surgery. Material and methods: As part of this investigation, 71 individuals with single or multiple myomas who were hospitalized to the prenatal care unit and those who came to the emergency ward for selective caesarean section were selected for inclusion in this prospective observational study. Main outcome measures: Blood transfusion, postoperative ecobolic usage, time required for surgery, problems during surgery, re-laparotomy to control bleeding or to perform hysterectomies, postoperative complications, and length of stay following surgery are all factors to consider. Results: There is no longer any danger in doing a myomectomy during a caesarean section, as previously stated. The average blood loss during surgery is 518.3 + 80.9 mm3, not including bleeding from the CS incision. There was no significant bleeding following surgery. The preoperative mean HB level/dl was 10.35 + 0.7, while the postoperative mean level/dl was 10.08 + 0.9. There were no postoperative complications for 84.4 percent of the women who had surgery. 82.2 percent of myomas occur in the uterine body, and the most prevalent kind is intramural [75.6 percent ]. Sixty-six percent of women had a myoma that was no larger than 5 centimeters. A caesarean myomectomy was accomplished in 80% of instances in less than an hour. After the birth of the infant, in 93.3 percent of instances, a myomectomy was performed. There was never a single occurrence of morbid fever. Myomectomy was performed successfully in all 71 of the patients who were admitted to the hospital following the procedure.